Page 11 - Avoid Food and Drug Interactions
P. 11
© 2019 ASPEN | American Society for Parenteral and Enteral Nutrition. All Rights Reserved. Disclosures
© 2019 ASPEN | American Society for Parenteral and Enteral Nutrition. All Rights Reserved. • In the past year I have been a speaker and consultant for
Fresenius Kabi and have received honoraria and consultant fees.
• I have also received a consultant fee from Baxter Healthcare from
participation .in a Technical Advisory Board
17
Learning Objectives
Upon completion of this session, the learner will be able to….
1. Explain why PN should not be avoided
2. Describe best practices for the appropriate use of PN
3. Improve the safety and efficacy of PN
18
11

